Joakim Håkansson Selected Research

hydroxypropylcellulose (hydroxypropyl cellulose)

5/2015	Efficacy and safety profile of the novel antimicrobial peptide PXL150 in a mouse model of infected burn wounds.
5/2014	Efficacy of the novel topical antimicrobial agent PXL150 in a mouse model of surgical site infections.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joakim Håkansson Research Topics

Disease

7	Neoplasms (Cancer) 07/2021 - 03/2006
6	Wounds and Injuries (Trauma) 12/2021 - 05/2014
6	Communicable Diseases (Infectious Diseases) 01/2019 - 12/2012
5	Breast Neoplasms (Breast Cancer) 07/2021 - 08/2020
5	Infections 01/2021 - 12/2012
3	Soft Tissue Infections 09/2022 - 04/2013
3	Surgical Wound Infection 01/2019 - 05/2014
2	Wound Infection (Wound Infections) 09/2022 - 01/2019
2	Carcinogenesis 03/2006 - 03/2005
1	Hypoxia (Hypoxemia) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Cicatrix (Scar) 01/2020
1	Hernia (Hernias) 01/2020
1	Burns 05/2015
1	Type 2 Diabetes Mellitus (MODY) 11/2011
1	Pathologic Neovascularization 01/2011
1	Hyperinsulinism (Hyperinsulinemia) 07/2009
1	Glucose Intolerance 07/2009
1	Neoplasm Metastasis (Metastasis) 03/2006
1	Fibrosarcoma 03/2006
1	Insulinoma 03/2006
1	Necrosis 10/2004

Drug/Important Bio-Agent (IBA)

7	Antimicrobial PeptidesIBA 10/2019 - 12/2012
6	Pharmaceutical PreparationsIBA 07/2021 - 05/2015
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2020
3	Adenosine Monophosphate (AMP)IBA 01/2021 - 12/2012
3	Peptides (Polypeptides)IBA 01/2021 - 05/2014
3	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 07/2009 - 03/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 09/2022 - 01/2019
2	Fusidic Acid (Fucithalmic)IBA 09/2022 - 01/2021
2	Hyaluronic Acid (Hyaluronan)IBA 01/2020 - 01/2017
2	hydroxypropylcellulose (hydroxypropyl cellulose)FDA Link 05/2015 - 05/2014
2	Anti-Infective Agents (Microbicides)IBA 05/2014 - 12/2012
1	Local Anti-Infective Agents (Antiseptics)IBA 12/2021
1	TEMPOIBA 07/2021
1	Fluorouracil (Carac)FDA LinkGeneric 01/2021
1	GelsIBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	AlginatesIBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	retapamulin FDA Link 01/2021
1	matrigelIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 08/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2020
1	Polysaccharides (Glycans)IBA 01/2020
1	Hematoxylin (Haematoxylon)IBA 01/2020
1	Poloxamer (Poloxamer 407)IBA 01/2019
1	HydrogelsIBA 01/2019
1	Antimicrobial Cationic PeptidesIBA 01/2019
1	Biocompatible Materials (Biomaterials)IBA 01/2017
1	SolutionsIBA 05/2014
1	Rosiglitazone (Avandia)FDA Link 11/2011
1	Oxygen (Dioxygen)IBA 01/2011
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 03/2006
1	Insulin (Novolin)FDA Link 10/2004

Therapy/Procedure

3	Therapeutics 01/2021 - 05/2015
1	Artificial Skin 09/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Punctures 01/2020
1	Aftercare (After-Treatment) 11/2011